Cosmos Health (COSM) is entering the final stage of development for CCX0722, its weight management solution. The Company is currently finalizing the scale-up production phase, paving the way for human clinical trials and targeting a market launch in the first or second quarter of 2026. Building on the completion of pilot production and previous development milestones, Cosmos Health is now actively engaging with Contract Research Organizations to complete the technical dossier, and clinical trials are set to be completed between the end of 2025 and the beginning of 2026.
Maximize Your Portfolio with Data Driven Insights:
Leverage the power of TipRanks’ Smart Score, a data-driven tool to help you uncover top performing stocks and make informed investment decisions.
Monitor your stock picks and compare them to top Wall Street Analysts’ recommendations with Your Smart Portfolio
Cosmos enters final development phase of CCX0722 weight managment solution
